...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and pharmacological characterization of 2-(acylamino)thiophene derivatives as metabolically stable, orally effective, positive allosteric modulators of the GABA_B receptor
【24h】

Synthesis and pharmacological characterization of 2-(acylamino)thiophene derivatives as metabolically stable, orally effective, positive allosteric modulators of the GABA_B receptor

机译:GABA_B受体的代谢稳定,口服有效,正构构调节剂2-(酰基氨基)噻吩衍生物的合成和药理学表征

获取原文
获取原文并翻译 | 示例

摘要

Two recently reported hit compounds, COR627 and COR628, underpinned the development of a series of 2-(acylamino)thiophene derivatives. Some of these compounds displayed significant activity in vitro as positive allosteric modulators of the GABA_B receptor by potentiating GTPγS stimulation induced by GABA at 2.5 and 25 μM while failing to exhibit intrinsic agonist activity. Compounds were also found to be effective in vivo, potentiating baclofen-induced sedation/hypnosis in DBA mice when administered either intraperitoneally or intragastrically. Although displaying a lower potency in vitro than the reference compound GS39783, the new compounds 6, 10, and 11 exhibited a higher efficacy in vivo: combination of these compounds with a per se nonsedative dose of baclofen resulted in shorter onset and longer duration of the loss of righting reflex in mice. Test compounds showed cytotoxic effects at concentrations comparable to or higher than those of GS39783 or BHF177.
机译:最近报道的两种热门化合物COR627和COR628支持了一系列2-(酰基氨基)噻吩衍生物的开发。这些化合物中的一些通过增强2.5和25μM的GABA诱导的GTPγS刺激而在体外显示出作为GABA_B受体的正变构调节剂的显着活性,而没有表现出固有的激动剂活性。还发现化合物在体内是有效的,当腹膜内或胃内给药时,可增强巴氯芬诱导的DBA小鼠的镇静/催眠作用。尽管在体外显示出比参考化合物GS39783更低的效价,但新化合物6、10和11在体内显示出更高的功效:这些化合物与本身非镇静剂量的巴氯芬合用会导致更短的发作和更长的持续时间。小鼠扶正反射丧失。测试化合物在与GS39783或BHF177相当或更高的浓度下显示出细胞毒性作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号